Cytosorbents Corp [CTSO] stock is trading at $0.89, up 6.54%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The CTSO shares have gain 10.26% over the last week, with a monthly amount drifted -2.91%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Cytosorbents Corp [NASDAQ: CTSO] stock has seen the most recent analyst activity on September 07, 2023, when B. Riley Securities initiated its Buy rating and assigned the stock a price target of $4. On September 17, 2020, Jefferies initiated with a Buy rating and assigned a price target of $15 on the stock. SVB Leerink started tracking the stock assigning a Outperform rating and suggested a price target of $15 on September 01, 2020. Maxim Group reiterated its recommendation of a Buy and raised its price target to $12 on August 08, 2017. In a note dated May 24, 2016, Maxim Group initiated an Buy rating and provided a target price of $8 on this stock.
Cytosorbents Corp [CTSO] stock has fluctuated between $0.70 and $1.82 over the past year. Cytosorbents Corp [NASDAQ: CTSO] shares were valued at $0.89 at the most recent close of the market.
Analyzing the CTSO fundamentals
Cytosorbents Corp [NASDAQ:CTSO] reported sales of 37.74M for the trailing twelve months, which represents a growth of 6.58%. Gross Profit Margin for this corporation currently stands at 1.0% with Operating Profit Margin at -0.0%, Pretax Profit Margin comes in at -0.27%, and Net Profit Margin reading is -0.27%. To continue investigating profitability, this company’s Return on Assets is posted at -49.17, Equity is -130.69 and Total Capital is -0.55. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of1.06.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.8688 points at the first support level, and at 0.8444 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.9188, and for the 2nd resistance point, it is at 0.9444.
Ratios To Look Out For
For context, Cytosorbents Corp’s Current Ratio is 1.97. As well, the Quick Ratio is 1.58, while the Cash Ratio is 0.67. Considering the valuation of this stock, the price to sales ratio is 1.30, the price to book ratio is 3.74.
Transactions by insiders
Recent insider trading involved MARIANI PETER J, Chief Financial Officer, that happened on Dec 13 ’24 when 20000.0 shares were purchased. Chief Financial Officer, MARIANI PETER J completed a deal on Dec 12 ’24 to buy 20000.0 shares. Meanwhile, Chief Financial Officer MARIANI PETER J bought 11363.0 shares on Dec 11 ’24.
